77156 Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices 

September 30, 2025, consistent with 

E.O. 14109 (September 29, 2023). 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. The 

ABRWH Subcommittee on Procedure 

Reviews (SPR) is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor (Oak 

Ridge Associated Universities—ORAU). 

Matters to be Considered: The 

meeting agenda will include discussions 

on the following: (1) Carry-over items 

from March 14, 2024 SPR meeting, 

including a. DCAS–PER–040 

‘‘Mallinckrodt TBD Revisions,’’ b. 

DCAS–PER–068 ‘‘Electro Metallurgical 

Co’’, c. DCAS–PER–070 ‘‘Nuclear Metals 

Inc.’’, d. DCAS–PER–072 ‘‘Seymour 

Specialty Wiring Co’’, e. ORAUT– 

RPRT–0060 ‘‘Neutron Dose from Highly 

Enriched Uranium’’, and f. DR template 

reviews—findings versus observations; 

(2) Newly issued SC&A reviews, 

including a. ORAUT–OTIB–0036 

‘‘Internal Dosimetry Coworker Data for 

Portsmouth Gaseous Diffusion Plant’’ b. 

ORAUT–OTIB–0040 ‘‘External 

Coworker Dosimetry Data for the 

Portsmouth Gaseous Diffusion Plant’’ c. 

ORAUT–OTIB–0093 ‘‘Conversion of 

Committed Effective Dose to Annual 

Organ Dose’’ and d. ORAUT–RPRT– 

0087 ‘‘Applications of Regression in 

External Dose Reconstruction’’; (3) 

Preparation for August 2024 Full 

ABRWH Meeting: Review of technical 

guidance documents ready for full 

Board approval; (4) Newly Issued 

Guidance and Supplemental Topics. 

Agenda items are subject to change as 

priorities dictate. For additional 

information, please contact Toll Free 

1(800) 232–4636. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–21497 Filed 9–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Board on 

Radiation and Worker Health, National 

Institute for Occupational Safety and 

Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Board on Radiation and Worker Health 

(ABRWH or the Advisory Board). This 

is a virtual meeting. It is open to the 

public, but without a public comment 

period. The public is welcome to submit 

written comments in advance of the 

meeting, to the contact person listed in 

the addresses section below. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. The public is also 

welcomed to listen to the meeting by 

joining the teleconference (information 

below), limited only by the number of 

audio conference lines available (150). 

DATES: The meeting will be held on 

October 9, 2024, from 11 a.m. to 1 p.m., 

EDT. 

Written comments must be received 

on or before October 2, 2024. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, Ph.D., 

National Institute for Occupational 

Safety and Health, 1090 Tusculum 

Avenue, Mailstop C–24, Cincinnati, 

Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 1– 

866–659–0537; the pass code is 

9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety & Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone 

(513) 533–6800, Toll Free 1(800) 232– 

4636, Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines 

which have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule, advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

14109 (September 29, 2023) on March 

22, 2024. Unless continued by the 

President the Board will terminate on 

September 30, 2025, consistent with 

E.O. 14109 of (September 29, 2023). 

Purpose: This Advisory Board is 

charged with a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under E.O. 13179; b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and c) upon request by 

the Secretary, HHS, advising the 

Secretary on whether there is a class of 

employees at any Department of Energy 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: Update on Cybersecurity 

Modernization Initiative; Work Group 

and Subcommittee reports; Update on 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices 77157 

the status of SEC Petitions; and plans for 

the December 2024 Advisory Board 

Meeting. Agenda items are subject to 

change as priorities dictate. For 

additional information, please contact 

Toll Free 1(800) 232–4636. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–21496 Filed 9–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–24FA] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘HumanCentered Design Effort on Bringing 

Guidelines to the Digital Age’’ to the 

Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on May 7, 2024 to obtain 

comments from the public and affected 

agencies. CDC received two comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Human-Centered Design Effort on 

Bringing Guidelines to the Digital Age— 

Existing Collection in Use Without an 

OMB Control Number—Office of Public 

Health Data, Surveillance, and 

Technology (OPHDST), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Given the increased demand to 

improve clinical guideline development 

and implementation, a new approach 

that began with an initiative on 

Adapting Clinical Guidelines for the 

Digital Age has been expanded by 

Guidelines International Network North 

America to implement a future state of 

guideline development and 

implementation that leverages 

advancements in technology. To 

identify pain points in the process, there 

were discussions with individuals from 

multiple perspectives in guidelines 

development and implementation. 

CDC requests approval for an Existing 

Collection in Use Without an OMB 

Control Number, for Human-Centered 

Design Effort on Bringing Guidelines to 

the Digital Age. Data from this project 

will be used to inform the structure of 

a human-centered design workshop 

where participants use the pain points 

identified from the semi-structured 

interviews as the starting point for 

exploring insights about guideline 

development and implementation. 

The burden estimates include the 

time for respondents to be interviewed. 

The estimated annual burden for 

respondents 33 hours. There is no cost 

to respondents other than their time to 

participate. 

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Clinicians ......................................................... Clinician Conversation Guide ......................... 5 1 1 

EHR Vendors .................................................. EHR Vendor Conversation Guide .................. 2 1 1 

Guideline Developers ...................................... Guideline Developer Conversation Guide ..... 8 1 1 

Informaticists ................................................... Informaticist Conversation Guide ................... 4 1 1 

Implementers .................................................. Implementer Conversation Guide .................. 9 1 1 

Insurers ........................................................... Insurer Conversation Guide ........................... 1 1 1 

Patient/Patient Advocate ................................. Patient/Patient Advocate Conversation Guide 4 1 1 


ddrumheller on DSK120RN23PROD with NOTICES1